APA (7th ed.) Citation

Ehrenreich, H., Weissenborn, K., Begemann, M., Busch, M., Vieta, E., & Miskowiak, K. W. (2020). Erythropoietin as candidate for supportive treatment of severe COVID-19. Molecular medicine (Cambridge, Mass.), 26(1), 58-9. https://doi.org/10.1186/s10020-020-00186-y

Chicago Style (17th ed.) Citation

Ehrenreich, Hannelore, Karin Weissenborn, Martin Begemann, Markus Busch, Eduard Vieta, and Kamilla W. Miskowiak. "Erythropoietin as Candidate for Supportive Treatment of Severe COVID-19." Molecular Medicine (Cambridge, Mass.) 26, no. 1 (2020): 58-9. https://doi.org/10.1186/s10020-020-00186-y.

MLA (9th ed.) Citation

Ehrenreich, Hannelore, et al. "Erythropoietin as Candidate for Supportive Treatment of Severe COVID-19." Molecular Medicine (Cambridge, Mass.), vol. 26, no. 1, 2020, pp. 58-9, https://doi.org/10.1186/s10020-020-00186-y.